Skip to main content
OpenTrials

Clinical trial condition

Pyogenic arthritis, pyoderma gangrenosum, and acne

Explore clinical trials studying Pyogenic arthritis, pyoderma gangrenosum, and acne. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Pyogenic arthritis, pyoderma gangrenosum, and acne trial results

Completed

A Study of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin) in Participants With Solid Tumors

NCT03386942

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Eisai Trial Site 5 Matsuyama, Ehime, Japan
  • Eisai Trial Site 6 Kurume, Fukuoka, Japan
  • Eisai Trial Site 8 Sapporo, Hokkaido, Japan
  • Eisai Trial Site 4 Akashi, Hyōgo, Japan
View Trial Details

Related conditions